Basic Medical Research Training in Oncology

肿瘤学基础医学研究培训

• 批准号: 10197779
• 负责人: OLUFUNMILAYO F. OLOPADE
• 金额: $ 50.65万
• 依托单位: UNIVERSITY OF CHICAGO
• 依托单位国家: 美国
• 财政年份: 1987
• 资助国家: 美国
• 起止时间: 1987-09-05 至 2023-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10197779
• 关键词: Medical Research; Oncology; Research Training

PROJECT SUMMARY The objective of the University of Chicago training program in Basic Medical Oncology is to provide an outstanding interdisciplinary research training environment for postdoctoral fellows who have completed internal medicine residency training in order to prepare them for research-intensive careers in academia, government, industry and community based practices. Candidates for T32 training are recruited from the ACGME-accredited hematology/oncology training in the Section of Hematology/Oncology within our Department of Medicine with the expectation that candidates for T32 training will complete one clinical year funded by the hospital and then have a minimum of two or three years of research training under the proposed training grant depending on whether they perform patient-oriented research or fundamental basic/translational/population research. The direction of the program – provision of multidisciplinary, structured, career development, advising and learning opportunities in cancer research – has not changed since the program's inception, but we have continued to evolve the program in response to a national need to develop and/or enhance research training opportunities for individuals from diverse backgrounds interested in team science and translational research. There are several unique structural elements in the research training proposed: 1) access to a diverse population of cancer patients; 2) training under the guidance of multidiciplinary research preceptor(s) within a robust scientific environment that provides innovative scientific approaches, tools and technologies; 3) specific educational pathways in the form of course work and special seminars leading to a Masters degree from any relevant unit in the University; and 4) service learning opportunities to improve health equity in our catchment area on the Southside of Chicago and across the globe. The 33 Senior and 22 Clinical/Junior research training faculty preceptors have NIH or equivalent peer- reviewed funding, interact on a number of collaborative research and training efforts and are well qualified to serve as potential mentors for the six trainees per year participating in this T32 program. In the proposed grant period, we shall continue the successful elements of the program in Clinical Pharmacology, Genomics and Immunotherapy. At the same time, we shall enhance the curricular offerings by providing coursework in emerging areas of cancer research including Epigenetics, Metabolomics, Medical Informatics, Quality of Care, Implementation Science and Global Cancer Research. Our extensive inpatient and outpatient facilities promote a comprehensive clinical training experience, while our research laboratories allow for the acquisition of basic research skills. In addition, our diverse populations on the Southside of Chicago and our global partners will provide learning opportunities in community engaged research locally and at International sites to advance novel interventions to reduce the global burden of cancer. With the rapid pace of scientific advancement, a well trained oncology work force as proposed in this training program remains a wise investment for the nation.

项目摘要 芝加哥大学基础医学肿瘤学培训计划的目标是提供 优秀的跨学科研究培训环境博士后研究员谁已经完成 内科住院医师培训，以便为他们在学术界的研究密集型职业做好准备， 政府、行业和社区为基础的做法。T32培训的候选人从 ACGME认证的血液学/肿瘤学培训，在我们的血液学/肿瘤学部门 医学系，期望T32培训的候选人将完成一个临床年 由医院资助，然后在研究培训下至少两三年 建议的培训补助金取决于他们是否进行以病人为导向的研究或基础 基础/转化/人口研究。该计划的方向-提供多学科，结构化， 职业发展，建议和学习机会在癌症研究-没有改变，因为 计划的开始，但我们继续发展该计划，以应对国家发展的需要， 和/或为来自不同背景的对团队感兴趣的个人增加研究培训机会 科学和转化研究。研究性训练有几个独特的结构要素 建议：1）接触不同人群的癌症患者; 2）在 多学科研究导师在一个强大的科学环境，提供创新的科学 方法、工具和技术; 3）以课程工作和特别 研讨会导致硕士学位从任何相关单位在大学;和4）服务学习 改善芝加哥南部集水区和整个 地球仪。33名高级和22名临床/初级研究培训教师导师拥有NIH或同等学历。 审查资金，在一些合作研究和培训工作中进行互动，并有资格 作为潜在的导师，为每年六名学员参加这个T32计划。在拟议的赠款中， 在此期间，我们将继续在临床药理学，基因组学和 免疫疗法与此同时，我们将通过提供以下课程来加强课程设置： 癌症研究的新兴领域，包括表观遗传学，代谢组学，医学信息学，护理质量， 实施科学和全球癌症研究。我们广泛的住院和门诊设施促进 全面的临床培训经验，而我们的研究实验室允许获得基本的 研究技能。此外，我们在芝加哥南部的多样化人口和我们的全球合作伙伴将 在当地和国际研究中心提供社区参与研究的学习机会， 新的干预措施，以减少全球癌症负担。随着科学进步的快速步伐， 本培训计划中提出的训练有素的肿瘤学工作人员仍然是国家的明智投资。